Merck Drn Ed Mb (MRCK34)
BOV
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 14.96B | 13.83B | 14.49B | 15.04B | 15.96B | 14.63B | 15.78B | 16.11B |
Operating Income | 4.01B | 3.44B | 3.74B | -5.17B | 5.75B | -1.97B | 5.64B | 6.05B |
Pre Tax Income | 3.58B | 3.51B | 3.65B | -5.34B | 5.62B | -2.05B | 5.67B | 6.01B |
Net Income | 3.25B | 3.02B | 2.82B | -5.98B | 4.75B | -1.23B | 4.76B | 5.46B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 4.29B | 3.7B | 3.4B | -4.97B | 5.98B | -1.71B | 5.84B | 6.18B |
EBITDA | 5.86B | 5.19B | 4.73B | -4.26B | 6.76B | -225M | 6.62B | 7.18B |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 39.81B | 40.12B | 42.29B | 46.84B | 47.99B | 48.7B | 59.28B | 60.12B |
Operating Income | 5.47B | 6.58B | 8.3B | 11.6B | 7.91B | 12.54B | 17.95B | 2.36B |
Pre Tax Income | 4.66B | 6.52B | 8.7B | 11.46B | 8.79B | 13.88B | 16.44B | 1.89B |
Net Income | 3.92B | 2.39B | 6.22B | 9.71B | 7.07B | 13.05B | 14.52B | 365M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 1.411 | 0.88 | 2.376 | 3.787 | 1.962 | 5.112 | 4.031 | 0.143 |
EBIT | 5.2B | 6.88B | 8.95B | 12.1B | 8.37B | 13.32B | 18.95B | 2.71B |
EBITDA | 11.38B | 11.79B | 12.75B | 15.43B | 13.25B | 16.03B | 23.6B | 7.01B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.